Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Role of Telomeres and Telomerase in Genomic Instability, Senescence and Cancer
Link ID 449
Title Role of Telomeres and Telomerase in Genomic Instability, Senescence and Cancer
Url http://www.medscape.com/viewarticle/564716?src=rss
Description Emerging anti-telomerase therapies that are currently in clinical trials might prove useful against some forms of human cancers.
Laboratory Investigation
Category Articles > Hematology-Oncology
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Histologic Considerations in Selecting Therapy for NSCLC: An Expert Interview With Dr. Chandra P. Be
  In this interview, Dr. Belani reviews data from recent trials and offers insights into how these findings associating histology and response might affect the treatment of patients with NSCLC. Medscape Psychiatry & Mental Health
Category:   Articles > Hematology-Oncology


2. A New Option for Advanced Prostate Cancer
  The newly approved taxane cabazitaxel has achieved significantly longer overall survival for advanced prostate cancer patients than earlier agents. Journal Watch
Category:   Articles > Hematology-Oncology


3. Novel Compound Holds Promise in High-Risk CLLNovel Compound Holds Promise in High-Risk CLL
  An experimental compound showed high efficacy and low toxicity in relapsed/refractory patients with chronic lymphocytic leukemia. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Radical Prostatectomy for Prostate Cancer: Who Benefits Most?
  A new study finds a clear survival benefit with radical prostatectomy vs watchful waiting, but only in men younger than 65. Dr. Gerald Chodak reviews the data. Medscape Urology
Category:   Articles > Hematology-Oncology


5. Decline in ADT Not at Expense of Men With Prostate Cancer
  The use of androgen-deprivation therapy (ADT) declined coincidentally with Medicare changes, but not in those who needed it most. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS